- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02703233
Effectiveness of Nitrous Oxide in the ED
July 8, 2016 updated by: Christiana Care Health Services
A Randomized Control Trial of Nitrous Oxide Use in the Emergency Department
This will be a randomized control trial.
All patients for whom an emergency provider determines that abscess drainage or laceration repair are necessary will be considered for enrollment.
The provider must be willing to participate in the study and be certified to use Nitrous oxide.
The investigators providers completed a training course to be certified to use Nitrous oxide.
The patient must be age 18 or greater, consent to participate in the study, and be able to complete a satisfaction survey.
If the patient states there is a possibility of pregnancy, the investigators will regress to our standard of care and perform a urine pregnancy test.
Patients with a first trimester pregnancy will be excluded.
Patients who agree to enroll in the study will be randomized to Nitrous oxide versus oxygen (to be administered through the same system), and will complete a survey after the procedure, as will the provider.
There will be a separate block randomization for each procedure.
Providers may select other agents of choice for analgesia/sedation, such as local anesthesia, and pain medications, based on their clinical judgment.
If the patient appears to have inadequate analgesia during the procedure, the provider can elect to treat as is typically done (pain medications or local anesthetics) at their discretion.
The survey will ask patients to give a self-reported pain score before and during their procedure (both to be completed after the procedure).
It will also ask the patient/guardian and provider for a satisfaction level with the analgesia during the procedure.
In addition, side effects and procedure start and stop time will also be documented.
In addition to the survey, the investigators will document clinical characteristics including diagnosis, size of laceration or abscess, additional medications required and dosages, comorbidities, age, and gender.
Other data that will be gathered will include which adjunctive analgesics/anesthetics were used.
Study Overview
Status
Withdrawn
Conditions
Intervention / Treatment
Study Type
Interventional
Phase
- Phase 4
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
Patients with:
- A laceration or an abscess requiring primary repair or incision and drainage respectively, per the treating provider
Exclusion Criteria:
- Age < 18 years
- First trimester pregnancy
- Inability to obtain written informed consent from subject or surrogate
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Nitrous Oxide
Patients receive nitrous oxide via mask.
|
|
Placebo Comparator: Placebo (Oxygen)
Patients receive oxygen via mask.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Visual Analog Pain Assessment Scale (0-10)
Time Frame: 0-20 minutes after drug administration
|
Pain score will be collected after drug administration
|
0-20 minutes after drug administration
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Provider satisfaction score
Time Frame: 0-20 minutes after drug administration
|
Provider satisfaction collected via survey post drug administration
|
0-20 minutes after drug administration
|
Patient satisfaction
Time Frame: 0-20 minutes after drug administration
|
Patient satisfaction collected via survey post drug administration
|
0-20 minutes after drug administration
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
March 1, 2016
Primary Completion (Anticipated)
March 1, 2018
Study Completion (Anticipated)
June 1, 2018
Study Registration Dates
First Submitted
February 24, 2016
First Submitted That Met QC Criteria
March 3, 2016
First Posted (Estimate)
March 9, 2016
Study Record Updates
Last Update Posted (Estimate)
July 11, 2016
Last Update Submitted That Met QC Criteria
July 8, 2016
Last Verified
July 1, 2016
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 602966
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Lacerations
-
University of PennsylvaniaTerminatedThrough-and-through Lip LacerationsUnited States
-
University of California, San FranciscoCentral California Faculty Medical GroupRecruiting
-
Universitätsklinikum Hamburg-EppendorfCompleted
-
University of Texas Southwestern Medical CenterCompletedPerineal LacerationsUnited States
-
Lund University HospitalCompletedPerineal LacerationsSweden
-
University of AarhusAarhus University Hospital; Danish Research Agency; Aase and Ejnar Danielsens... and other collaboratorsCompletedEpisiotomy | Perineal LacerationsDenmark
-
Boston Urogynecology AssociatesUnknownObstetric; Injury Pelvic Floor | Obstetrical LacerationsUnited States
-
Children's Hospitals and Clinics of MinnesotaCompletedFacial LacerationsUnited States
-
University of ManitobaUnknownZone 2 Flexor Tendon Lacerations of the HandCanada
-
OptMed, Inc.CompletedTraumatic Lacerations or Surgical IncisionsUnited States
Clinical Trials on Nitrous Oxide
-
University of ChicagoNational Institute on Drug Abuse (NIDA)CompletedSubstance-Related Disorders | Opioid-Related DisordersUnited States
-
State University of New York at BuffaloCompleted
-
Washington University School of MedicineBrain & Behavior Research FoundationCompletedDepressive Disorder, Major | Depressive Disorder, Treatment-ResistantUnited States
-
Beth Israel Deaconess Medical CenterRecruitingProcedural Pain | Pain Catastrophizing | Procedural AnxietyUnited States
-
Beth Israel Deaconess Medical CenterBoston Children's HospitalCompletedLower Urinary Tract SymptomsUnited States
-
Beth Israel Deaconess Medical CenterBrigham and Women's HospitalCompletedPain | Benign Prostatic Hyperplasia | Prostate Cancer | Prostate Adenocarcinoma | Anxiety and Fear | Malignancy | Prostate DiseaseUnited States
-
Washington University School of MedicineFoundation for Anesthesia Education and ResearchCompletedCardiovascular AbnormalitiesUnited States
-
National Institute of Diabetes and Digestive and...CompletedAvitaminosis | Delirium, Dementia, Amnestic, Cognitive DisordersUnited States
-
University of ChicagoNational Institute on Drug Abuse (NIDA)CompletedSubstance-Related Disorders | Opioid-Related DisordersUnited States
-
Baxter Healthcare CorporationCompleted